Pulmatrix Inc (PULM)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Robert W. Clarke
Employees:
22
99 HAYDEN AVENUE, SUITE 390, LEXINGTON, MA 02421
(781) 357-2333

Pulmatrix, Inc. is a clinical stage biotechnology company, which is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. It designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The company was founded by David Edwards, Mark Gabrielson, Alexander Klibanov, and Robert Langer in 2013 and is headquartered in Lexington, MA.

Data derived from most recent annual or quarterly report
Market Cap 39.374 Million Shares Outstanding56.249 Million Avg 30-day Volume 228.353 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 3.04 / 0.68 Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million
View SEC Filings from PULM instead.

View recent insider trading info

Funds Holding PULM (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PULM BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

VARADAN ANAND

  • Director
30,000 2021-07-26 2

IWICKI MARK T

  • Director
0 2021-01-28 1

HIGGINS MICHAEL J

  • Director
0 2021-01-28 1

BAZEMORE TODD

  • Director
0 2021-01-28 1

MUNSHI AMIT

  • Director
0 2021-01-28 1

BATYCKY RICHARD P.

  • Director
0 2021-01-28 1

RAAD TEOFILO DAVID CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2021-01-28 1

SIEGERT MICHELLE VICE PRESIDENT, FINANCE

  • Officer
0 2021-01-28 1

CABELL CHRISTOPHER

  • Director
0 2021-01-28 1

GILLIS STEVEN

  • Director
No longer subject to file 2020-08-28 0

MCGUIRE TERRANCE

  • Director
0 2019-05-16 0

SHERMAN MATTHEW L

  • Director
0 2019-05-16 0

DUKE WILLIAM E. CHIEF FINANCIAL OFFICER

  • Officer
0 2019-05-16 0

ROACH JAMES M. CHIEF MEDICAL OFFICER

  • Officer
0 2018-06-05 0

HAVA DAVID L. CHIEF SCIENTIFIC OFFICER

  • Officer
0 2018-06-05 0

CLARKE ROBERT W. CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2018-06-05 0

MCGUIRE TERRANCE

FLINT JONATHAN A

POLARIS VENTURE MANAGEMENT CO IV LLC

POLARIS VENTURE PARTNERS ENTREPRENEURS FUND IV LP

POLARIS VENTURE PARTNERS IV LP

POLARIS VENTURE MANAGEMENT CO. V, L.L.C.

POLARIS VENTURE PARTNERS ENTREPRENEURS' FUND V, L.P.

POLARIS VENTURE PARTNERS V, L.P.

POLARIS VENTURE PARTNERS FOUNDERS' FUND V, L.P.

POLARIS VENTURE PARTNERS SPECIAL FOUNDERS' FUND V, L.P.

  • Director
  • 10% Owner
5,180,235 2018-04-03 0

GILLIS STEVEN

ARCH VENTURE FUND VII LP

ARCH VENTURE PARTNERS VII, L.P.

ARCH VENTURE PARTNERS VII, LLC

CRANDELL KEITH

BYBEE CLINTON

NELSEN ROBERT

  • Director
  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
3,436,456 2018-04-03 0

ARCH VENTURE FUND VII LP

ARCH VENTURE PARTNERS VII, L.P.

ARCH VENTURE PARTNERS VII, LLC

CRANDELL KEITH

BYBEE CLINTON

NELSEN ROBERT

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2018-04-03 0

ROCKLAGE SCOTT M

  • Director
0 2016-02-03 0

GRAVES KURT

  • Director
0 2016-02-03 0

OCULUS INNOVATIVE SCIENCES, INC.

  • 10% Owner
0 2015-06-16 0

MAKI DAVID

  • Director
436,388 2015-06-15 0

AKAO AKIHISA

  • Director
0 2015-04-30 0

CONLEY RICHARD K

  • Director
0 2015-04-30 0

FRENCH GREGORY M

  • Director
0 2015-04-30 0

ALIMI HOJABR CEO AND CHIEF SCIENCE OFFICER

  • Officer
  • Director
125,000 2014-05-11 0

HARISH SAMEER CHIEF FINANCIAL OFFICER

  • Officer
74,600 2014-05-11 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

HIGGINS MICHAEL J - Director

2016-02-25 12:54:48 -0500 2026-02-03 A 8,800 a 8,800 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
PULMATRIX INC PULM 2021-10-26 19:15:03 UTC -8.7425 8.8125 300000
PULMATRIX INC PULM 2021-10-26 18:45:03 UTC -8.7425 8.8125 300000
PULMATRIX INC PULM 2021-10-26 18:15:03 UTC -8.7425 8.8125 300000
PULMATRIX INC PULM 2021-10-26 17:45:03 UTC -8.7425 8.8125 300000
PULMATRIX INC PULM 2021-10-26 17:15:03 UTC -8.7425 8.8125 300000
PULMATRIX INC PULM 2021-10-26 16:45:04 UTC -8.7425 8.8125 300000
PULMATRIX INC PULM 2021-10-26 16:15:03 UTC -8.7425 8.8125 300000
PULMATRIX INC PULM 2021-10-26 15:45:03 UTC -8.7425 8.8125 300000
PULMATRIX INC PULM 2021-10-26 15:15:03 UTC -8.7425 8.8125 300000
PULMATRIX INC PULM 2021-10-26 14:45:03 UTC -8.6835 8.7535 300000
PULMATRIX INC PULM 2021-10-26 14:15:05 UTC -8.6835 8.7535 300000
PULMATRIX INC PULM 2021-10-26 13:45:03 UTC -8.6835 8.7535 300000
PULMATRIX INC PULM 2021-10-26 13:15:03 UTC -8.6835 8.7535 300000
PULMATRIX INC PULM 2021-10-26 12:45:03 UTC -8.6835 8.7535 300000
PULMATRIX INC PULM 2021-10-25 22:15:03 UTC -8.6835 8.7535 300000
PULMATRIX INC PULM 2021-10-25 21:45:03 UTC -8.6835 8.7535 300000
PULMATRIX INC PULM 2021-10-25 21:15:03 UTC -8.6835 8.7535 300000
PULMATRIX INC PULM 2021-10-25 20:45:03 UTC -8.6835 8.7535 300000
PULMATRIX INC PULM 2021-10-25 20:15:03 UTC -8.6835 8.7535 300000
PULMATRIX INC PULM 2021-10-25 19:45:04 UTC -8.6835 8.7535 300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund PULM -1000.0 shares, $-1040.0 2021-06-30 N-PORT

Elevate your investments